These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 20205345

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients.
    Hiligsmann M, Rabenda V, Bruyère O, Reginster JY.
    Health Policy; 2010 Jul; 96(2):170-7. PubMed ID: 20153543
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR, Graham CN, Ettinger B, Amonkar MM, Lynch NO, Middelhoven H.
    Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
    [Abstract] [Full Text] [Related]

  • 6. Effect of adherence on lifetime fractures in osteoporotic women treated with daily and weekly bisphosphonates.
    Danese MD, Badamgarav E, Bauer DC.
    J Bone Miner Res; 2009 Nov; 24(11):1819-26. PubMed ID: 19419313
    [Abstract] [Full Text] [Related]

  • 7. Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US.
    Parthan A, Kruse M, Yurgin N, Huang J, Viswanathan HN, Taylor D.
    Appl Health Econ Health Policy; 2013 Oct; 11(5):485-97. PubMed ID: 23868102
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates.
    Rietbrock S, Olson M, van Staa TP.
    QJM; 2009 Jan; 102(1):35-42. PubMed ID: 18842684
    [Abstract] [Full Text] [Related]

  • 10. [The necessity of cost-effectiveness analysis in osteoporosis].
    Lamy O, Krieg MA.
    Rev Med Suisse; 2007 Jun 13; 3(115):1521-5. PubMed ID: 17682796
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
    Ito K, Blinder VS, Elkin EB.
    J Clin Oncol; 2012 May 01; 30(13):1468-75. PubMed ID: 22370313
    [Abstract] [Full Text] [Related]

  • 13. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
    Cramer JA, Amonkar MM, Hebborn A, Altman R.
    Curr Med Res Opin; 2005 Sep 01; 21(9):1453-60. PubMed ID: 16197664
    [Abstract] [Full Text] [Related]

  • 14. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.
    Int J Clin Pharmacol Res; 2004 Sep 01; 24(1):1-10. PubMed ID: 15575171
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands.
    Jansen JP, Gaugris S, Bergman G, Sen SS.
    Curr Med Res Opin; 2008 Mar 01; 24(3):671-84. PubMed ID: 18221588
    [Abstract] [Full Text] [Related]

  • 16. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P, De Groote K, Annemans L.
    Arch Orthop Trauma Surg; 2004 Oct 01; 124(8):507-17. PubMed ID: 15365714
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.
    Hiligsmann M, Boonen A, Rabenda V, Reginster JY.
    Expert Rev Pharmacoecon Outcomes Res; 2012 Apr 01; 12(2):159-66. PubMed ID: 22458617
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.